Controlling gene activation by enhancers through a drug-inducible topological insulator.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32369019.
- Also identified by DOI 10.7554/eLife.47980 and PMC identifier 7200164.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
While regulation of gene-enhancer interaction is intensively studied, its application remains limited. Here, we reconstituted arrays of CTCF-binding sites and devised a <u>s</u>ynthetic <u>t</u>opological <u>i</u>nsulator with <u>t</u>etO for <u>ch</u>romatin-engineering (STITCH). By coupling STITCH with tetR linked to the KRAB domain to induce heterochromatin and disable the insulation, we developed a drug-inducible system to control gene activation by enhancers. In human induced pluripotent stem cells, STITCH inserted between <i>MYC</i> and the enhancer down-regulated <i>MYC.</i> Progressive mutagenesis of STITCH led to a preferential escalation of the gene-enhancer interaction, corroborating the strong insulation ability of STITCH. STITCH also altered epigenetic states around <i>MYC</i>. Time-course analysis by drug induction uncovered deposition and removal of H3K27me3 repressive marks follows and reflects, but does not precede and determine, the expression change. Finally, STITCH inserted near <i>NEUROG2</i> impaired the gene activation in differentiating neural progenitor cells. Thus, STITCH should be broadly useful for functional genetic studies.
Medical subject headings
- Chromatin
- Enhancer Elements, Genetic
- Gene Expression Regulation
- Genes